Medical conditions such as polycystic ovary syndrome (PCOS) or thyroid disorders can also disrupt your menstrual cycle
These trials established dose escalation protocols and safety profiles across diverse populations
To view a copy of this licence, visit About this article Cite this article Osmanlolu, H.., Nazrolu, M
The results suggested that BBR modulates IgE expression at the transcriptional level, through inhibition of STAT6 binding through B cell lymphoma (BCL)-6 at the IgE heavy chain promoter [50]
Emerging research suggests genetic variation in GLP-1 receptor expression, intestinal permeability genes, and microbiota-related pathways may influence side effect susceptibility
GLP-1 drugs are not a substitute for established substance use disorder treatments, and any changes in substance use patterns should be monitored by healthcare providers